Hereditary Angioedema
Top in allergy/asthma: Understanding employment laws; barzolvolimab improves urticaria
Practice owners and directors should familiarize themselves with local and federal employment laws because the penalties for noncompliance can be severe, according to employment lawyer Penelope J. Phillips, JD.
Patients experience rapid relief from hereditary angioedema attacks with sebetralstat
WASHINGTON — Patients with hereditary angioedema experienced rapid symptom relief with sebetralstat compared with placebo, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Study reveals hereditary angioedema experiences among underrepresented populations
WASHINGTON — Patients from underrepresented groups experienced improved control of their hereditary angioedema after diagnosis, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual meeting.
Berotralstat achieves long-term prophylaxis for hereditary angioedema attacks
Patients with hereditary angioedema who used berotralstat generally tolerated treatment and experienced reductions in attacks over 96 weeks, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Garadacimab application accepted for FDA review in hereditary angioedema treatment
The FDA has accepted a biologics license application for garadacimab as a monthly prophylactic treatment for hereditary angioedema, according to a press release from the manufacturer.
Hereditary angioedema attacks cease after tranexamic acid treatment
ANAHEIM, Calif. — A patient with hereditary angioedema and a plasminogen gene mutation did not have any attacks with tranexamic acid, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Hereditary angioedema burdens include quality of life, health care costs
Patients with hereditary angioedema experience significant burdens in disease control, quality of life, treatment satisfaction and societal costs, reported a study published in The Journal of Allergy and Clinical Immunology: In Practice.
FDA fast tracks first-line treatment for hereditary angioedema attacks
The FDA has granted fast-track status to STAR-0215, a potential first-line treatment to prevent attacks of hereditary angioedema, Astria Therapeutics Inc. announced in a company press release.
Top in allergy/asthma: Peanut patch for toddlers; hereditary angioedema attacks
Sixty-seven percent of toddlers who were allergic to peanuts had a boost in their tolerance after being treated with a Viaskin Peanut patch for 12 months, recent data show.
Prophylaxis reduces number of hereditary angioedema attacks requiring acute care
Patients with hereditary angioedema using modern prophylaxis had fewer attacks needing icatibant or C1-INH IV than patients on other therapies, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.